Su Min Ha1, Jae Kyun Kim1, Jung Hwan Baek2. 1. 1 Department of Radiology and Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine , Seoul, Korea. 2. 2 Department of Radiology and the Research Institute of Radiology, University of Ulsan College of Medicine , Asan Medical Center, Seoul, Korea.
Abstract
BACKGROUND: In patients undergoing active surveillance of papillary thyroid microcarcinoma, definitive therapy-usually preceded by a definitive diagnostic procedure-is not recommended until evidence of disease progression is obtained, as stated in the American Thyroid Association guidelines. This is because the deferring of definitive diagnosis and therapy until disease progression has no impact on the disease-specific survival. This study evaluated the malignancy rate and probability of thyroid nodules, which was further stratified based on the size cutoff value of 1 cm, with suspicious findings on ultrasonography (US), by using various malignant stratification systems. METHODS: The data were retrospectively collected between January 2003 and June 2003 from nine university hospitals that had previously participated in the Korean Society of Thyroid Radiology multicenter study on the ultrasonographic differentiation between benign and malignant thyroid nodules. In total, 829 thyroid nodules from 711 patients (620 women, 91 men; Mage = 48.7 years; range 6-98 years; 351 malignant and 478 benign nodules) were included. The probability for malignancy of thyroid nodules was calculated, which was further stratified by size, by using four different types of malignant risk-stratification systems. The factors that could differentiate benign from malignant nodules were assessed using the chi-square test. RESULTS: In the suspicious thyroid nodules <1 cm on US, the malignancy probability ranged from 77.4% to 82.8%; the lowest rate was found in the Korean Society of Thyroid Radiology multicenter study, whereas the highest rate was noted in the Web-based system. Thus, the probability of benign nodules among suspicious thyroid nodules <1 cm on US was 17.2-22.6%. CONCLUSION: A biopsy should be considered before active surveillance to exclude benign nodules with suspicious US features, and could thus prevent unnecessary active surveillance and patient anxiety.
BACKGROUND: In patients undergoing active surveillance of papillary thyroid microcarcinoma, definitive therapy-usually preceded by a definitive diagnostic procedure-is not recommended until evidence of disease progression is obtained, as stated in the American Thyroid Association guidelines. This is because the deferring of definitive diagnosis and therapy until disease progression has no impact on the disease-specific survival. This study evaluated the malignancy rate and probability of thyroid nodules, which was further stratified based on the size cutoff value of 1 cm, with suspicious findings on ultrasonography (US), by using various malignant stratification systems. METHODS: The data were retrospectively collected between January 2003 and June 2003 from nine university hospitals that had previously participated in the Korean Society of Thyroid Radiology multicenter study on the ultrasonographic differentiation between benign and malignant thyroid nodules. In total, 829 thyroid nodules from 711 patients (620 women, 91 men; Mage = 48.7 years; range 6-98 years; 351 malignant and 478 benign nodules) were included. The probability for malignancy of thyroid nodules was calculated, which was further stratified by size, by using four different types of malignant risk-stratification systems. The factors that could differentiate benign from malignant nodules were assessed using the chi-square test. RESULTS: In the suspicious thyroid nodules <1 cm on US, the malignancy probability ranged from 77.4% to 82.8%; the lowest rate was found in the Korean Society of Thyroid Radiology multicenter study, whereas the highest rate was noted in the Web-based system. Thus, the probability of benign nodules among suspicious thyroid nodules <1 cm on US was 17.2-22.6%. CONCLUSION: A biopsy should be considered before active surveillance to exclude benign nodules with suspicious US features, and could thus prevent unnecessary active surveillance and patientanxiety.
Authors: Liu Yihao; Li Shuo; Xi Pu; Wang Zipeng; Sun Hanlin; Chang Qungang; Wang Yongfei; Yin Detao Journal: Int J Endocrinol Date: 2022-06-28 Impact factor: 2.803
Authors: Roussanka D Kovatcheva; Alexander D Shinkov; Inna D Dimitrova; Ralitsa B Ivanova; Kalin N Vidinov; Radina S Ivanova Journal: Eur Thyroid J Date: 2020-05-18
Authors: Simone Schenke; Rigobert Klett; Philipp Seifert; Michael C Kreissl; Rainer Görges; Michael Zimny Journal: J Clin Med Date: 2020-01-16 Impact factor: 4.241